Delivery Order SPE2DB24D8002-SPE2DB25FJNJD
Award Date
3/19/25
Potential Completion Date
3/20/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D8001|SPE2DB24FKZBP, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $9,198.65 firm fixed-price delivery order is for the provision of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC), valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT...
This contract, awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, provides for the delivery of the pharmaceutical product QULIPTA 60 MG TABLET 30S. The contract has a ceiling value of $11,738.78 and a period of performance through December 20, 2024. Dakota Drug, Inc. is an established federal contractor that has been awarded a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,031.98 firm fixed-price delivery order is for the provision of MENQUADFI VIAL 0.5ML medical supplies. The contract is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a ceiling value of $999,999,999.00 and allows the company to provide a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract worth $8,454.30 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a performance period through December 6, 2023. This delivery order is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical's ECAT...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZDT, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,528.94 and is a Firm Fixed Price Delivery Order. It is not associated with a set-aside program. Dakota...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of PROQUAD vials. The $2,580.94 contract has an ultimate completion date of January 17, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA's ECAT Generation V Program, which...
The federal contract award SPE2DX15D8002|SPE2DX24F2TS8, valued at $2,818.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the provision of PROQUAD VIALS, a pharmaceutical product. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,231.24 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, with the DLA as part of the ECAT Generation V...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,611.72 firm fixed-price delivery order is for the provision of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is associated with Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA,...